/Danaher%20Corp_%20logo%20on%20phone-by%20Piotr%20Swat%20via%20Shutterstock.jpg)
Washington, DC-based Danaher Corporation (DHR) is a leading global life sciences and diagnostics innovator, helping solve many of the world’s most important health challenges. It focuses on areas such as Life Sciences, Diagnostics, Biotechnology and more. Valued at $172.7 billion by market cap, Danaher employs over 61,000 people and operates in 50 different countries and 700 locations across the globe.
The healthcare giant is gearing up to announce its fourth-quarter earnings before the market opens on Wednesday, Jan. 29. Ahead of the event analysts expect Danaher to report a non-GAAP profit of $2.15 per share, up 2.9% from $2.09 per share reported in the year-ago quarter. The company has surpassed Wall Street’s bottom-line estimates in each of the past four quarters. Its adjusted EPS for the last reported quarter dropped marginally to $1.71 while beating analysts’ estimates of $1.56.